Agilent Technologies, Inc. (NYSE:A) Shares Sold by Burney Co.

Burney Co. decreased its position in Agilent Technologies, Inc. (NYSE:A) by 32.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,837 shares of the medical research company’s stock after selling 863 shares during the quarter. Burney Co.’s holdings in Agilent Technologies were worth $238,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of A. Financial Advocates Investment Management acquired a new stake in shares of Agilent Technologies during the second quarter worth approximately $348,000. HB Wealth Management LLC boosted its holdings in Agilent Technologies by 13.7% in the second quarter. HB Wealth Management LLC now owns 6,875 shares of the medical research company’s stock worth $891,000 after purchasing an additional 828 shares during the period. Cambridge Investment Research Advisors Inc. boosted its holdings in Agilent Technologies by 1.1% in the second quarter. Cambridge Investment Research Advisors Inc. now owns 13,298 shares of the medical research company’s stock worth $1,724,000 after purchasing an additional 148 shares during the period. AlphaStar Capital Management LLC boosted its holdings in Agilent Technologies by 24.7% in the second quarter. AlphaStar Capital Management LLC now owns 8,852 shares of the medical research company’s stock worth $1,148,000 after purchasing an additional 1,752 shares during the period. Finally, State of Michigan Retirement System boosted its holdings in Agilent Technologies by 1.2% in the second quarter. State of Michigan Retirement System now owns 84,181 shares of the medical research company’s stock worth $10,912,000 after purchasing an additional 1,000 shares during the period. Institutional investors and hedge funds own 87.42% of the company’s stock.

Agilent Technologies Stock Performance

A traded up $0.42 on Friday, hitting $142.95. The company had a trading volume of 29,485 shares, compared to its average volume of 1,733,531. The company’s fifty day moving average price is $134.59 and its 200 day moving average price is $138.72. Agilent Technologies, Inc. has a 1-year low of $96.80 and a 1-year high of $155.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. The stock has a market cap of $41.71 billion, a price-to-earnings ratio of 33.70, a price-to-earnings-growth ratio of 4.86 and a beta of 1.05.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company earned $1.43 EPS. The company’s revenue for the quarter was down 5.6% on a year-over-year basis. Equities analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Insider Activity

In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, SVP Dominique Grau sold 15,000 shares of the company’s stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the transaction, the senior vice president now directly owns 49,486 shares in the company, valued at $6,595,494.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total value of $274,120.00. Following the completion of the transaction, the chief executive officer now owns 26,076 shares of the company’s stock, valued at $3,650,640. The disclosure for this sale can be found here. Over the last three months, insiders sold 20,874 shares of company stock valued at $2,811,770. 0.33% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms have issued reports on A. Wells Fargo & Company began coverage on Agilent Technologies in a research note on Tuesday. They issued an “overweight” rating and a $157.00 target price on the stock. Wolfe Research cut shares of Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research note on Thursday, June 27th. Bank of America lifted their price objective on shares of Agilent Technologies from $140.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Stifel Nicolaus restated a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research note on Monday. Finally, Robert W. Baird cut their price objective on shares of Agilent Technologies from $147.00 to $136.00 and set an “outperform” rating on the stock in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $141.60.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.